Back
Verizon Communications, Inc. Vs. Kymera Therapeutics, Inc. Industry Stock Comparison
Sell
42
VZ
Verizon Communications, Inc.
Last Price:
$40.49
Seasonality Move:
1.59%
Buy
70
KYMR
Kymera Therapeutics, Inc.
Last Price:
$81.31
Seasonality Move:
-9.68%
Sell
42
Verizon Communications, Inc. (VZ)
is a Sell
Is Verizon Communications, Inc. a Buy, Sell or Hold?
-
The current Verizon Communications, Inc. [VZ] share price is $40.48. The Score for VZ is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
VZ is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
70
Kymera Therapeutics, Inc. (KYMR)
is a Buy
Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Kymera Therapeutics, Inc. [KYMR] share price is $81.32. The Score for KYMR is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
-
KYMR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VZ Stock Price Chart
What is Verizon Communications, Inc.'s stock price today?
-
The Verizon Communications, Inc. share price today is $40.48Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VZ is experiencing buying pressure, which is a positive indicator for future bullish movement.
KYMR Stock Price Chart
What is Kymera Therapeutics, Inc.'s stock price today?
-
The Kymera Therapeutics, Inc. share price today is $81.32The current trend is moderately bullish and KYMR is experiencing selling pressure, which indicates risk of future bearish movement.
VZ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 10.98 | Buy |
| Relative Strength Index (14 RSI): | 49.47 | Sell |
| Chaikin Money Flow: | 6946005 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (40.14 - 41.1) | Sell |
| Bollinger Bands (100): | (40.02 - 43.62) | Sell |
KYMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.49 | Buy |
| Relative Strength Index (14 RSI): | 56.33 | Buy |
| Chaikin Money Flow: | -289450 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (66.98 - 86.98) | Buy |
| Bollinger Bands (100): | (44.7 - 72.38) | Buy |
VZ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 40.32 | Buy |
| 20-day SMA: | 40.6 | Sell |
| 50-day SMA: | 40.35 | Buy |
| 200-day SMA: | 42.51 | Sell |
| 8-day EMA: | 33.32 | Buy |
| 20-day EMA: | 20.27 | Buy |
| 50-day EMA: | 9.83 | Buy |
| 200-day EMA: | 2.72 | Buy |
KYMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 82.78 | Sell |
| 20-day SMA: | 79.72 | Buy |
| 50-day SMA: | 69.02 | Buy |
| 200-day SMA: | 47.63 | Buy |
| 8-day EMA: | 82.78 | Sell |
| 20-day EMA: | 79.53 | Buy |
| 50-day EMA: | 71.06 | Buy |
| 200-day EMA: | 53.72 | Buy |
Verizon Communications, Inc. Earnings Growth & VZ Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and an increase next year of $0.11 per share.
Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.62 per share, and a decrease next year of $0.25 per share.
Verizon Communications, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Kymera Therapeutics, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||